Webinar

How full pharmacovigilance outsourcing increases efficiency and accuracy

  • PharmaLex, a Cencora company

In the face of increasing market pressures and an uncertain global environment, biopharmaceutical companies are seeking new avenues to help optimize efficiencies and cost structures. Leading organizations are finding success by shifting from functional outsourcing for pharmacovigilance areas such as case processing to a complete end-to-end pharmacovigilance outsourcing model. Join our webinar, "How full pharmacovigilance outsourcing increases efficiency and accuracy" on Wednesday, June 25th at 11am ET. Chris Englerth, our Director of Global Consulting Services, will moderate this session alongside Michael Marschler, our Senior Director of Pharmacovigilance.

Key learnings

  • Strengthened internal pharmacovigilance teams, allowing PV leaders and staff to focus on business-critical safety strategies and innovation
  • Reduced operational costs while improving reporting and oversight, maintaining or even enhancing patient safety
  • Scaled PV processes quickly and effectively based on demand, providing flexibility to support product development and commercialization strategies
  • Streamlined growth in new markets with global PV structures and processes harmonized locally, avoiding common risks and delays due to unfamiliarity with country-specific requirements

Access the recording

Pardot Form

Connect with our team

Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.

Related resources

Article

Harnessing AI and advanced analytics to revolutionize PV signal management

Article

The growing case for AI to support pharmacovigilance: World Drug Safety Congress Americas key takeaways

Article

Five frequent inspection findings and the role of the QPPV